Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-14-000126

Chief Scientific Officer acquired 180,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Radvanyi Laszlo · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2014-06-23 Grant or award : show line 1 in the form +180,000 180,000 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-06-23 Grant or award : show line 2 in the form Stock Option (right to buy) +180,000 $5.80 2024-06-22 180,000 180,000 D
Loading xslF345X03/primary_doc.xml…